In a new, national, hospital-based study, researchers at the American Cancer Society (ACS) found that Medicaid expansion was associated with a statistically significant reduction in early mortality following surgical resection of stage I-III non-small cell lung cancer (NSCLC).
Pharmalittle: We’re reading about a soft-tissue cancer drug approval, the Zepbound shortage ending, and more
Good morning, and happy Friday. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from
August 2, 2024